Publications

Legislators need to be prudent stewards of taxpayer dollars, but they must also ensure that vulnerable populations receive appropriate care. This Desktop Reference will help state legislators identify effective actions that may save the state money without reducing access to needed medicines. Topics include Medicaid restrictive formularies, importation/reimportation, purchasing coalitions, drug price controls, tort reform, counterfeit drugs, and direct-to-consumer advertising.

Republicans are supposed to provide a check on the big-government impulses of their Democratic brethren aren’t they? Oh, yea, forgot about Congress.

How does that old saying from philosopher George Santayana go? “Those who cannot remember the history of price controls are condemned to repeat them?” Or something like that.

Brand name pharmaceutical manufacturers are constantly berated by activists for not doing enough to help poor countries get essential medicines.

AOL is being blasted for announcing a new plan which involves charging marketers to ensure their emails reach their intended recipients.

Entrepreneurs—where would the economy be without them? Nowhere.

Politicians are once again flirting with price controls. A price is a powerful conveyor of information to both buyers and sellers. Most companies engage in "differential pricing," so that low-income people have access to their products. But price controls actually hurt low-income people because they keep prices artificially high, plus they stifle competition and destroy innovation.

Sens.

That might appear to be a rather unusual question.

Ten years ago last week, Bill Clinton signed what was sold to the public as a landmark telecommunications law.